logo
Send Message

Longilat Bio Latest News and Industry Trends

September 1, 2025

Latest company case about Longilat Bio Latest News and Industry Trends

1. High-Purity Tianeptine Sodium Powder

 

Longilat Bio produces high-purity, GMP-compliant Tianeptine Sodium powder specifically for research institutions, clinical trial support, and formulation development. All products undergo quality testing to ensure a purity of ≥98%, ensuring consistency and reliability in laboratory use.

 

2. Launch of Dehydrogingerone, a New Hot Spot in the Global API Market


Dehydrogingerone (CAS 1080-12-2), a natural plant extract, exhibits multiple pharmacological activities, including antioxidant, anti-inflammatory, and antimicrobial properties, and is widely used in disease treatment and health supplement manufacturing. The launch of this product has attracted widespread attention in the global pharmaceutical industry.

 

3. Focusing on metabolic health, research on retatrutide peptides continues to advance.

 

High-purity, GMP-compliant, lyophilized retatrutide peptides are available in 5mg, 10mg, 20mg, 30mg, and 40mg strengths. This product is designed for research institutions, clinical trial support, and formulation development, aiming to advance research in metabolic health.

 

4. Focus on Food-Grade Urolithin B Market Growth Trends

 

According to recent market research, the food-grade urolithin B market is projected to reach US$12.1 million in 2025, exhibiting a compound annual growth rate (CAGR) of 6% from 2019 to 2033. This growth is primarily driven by increasing consumer awareness of gut health and the potential health benefits of urolithin B in promoting healthy aging.

Get in touch with us
Contact Person : Mrs. Nancylee
Tel : +86 15508667508
Characters Remaining(20/3000)